Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.83 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.66 |
| ▸ | NAAA | Q02083 | 1/20 | 0.61 |
| ▸ | PAM | P19021 | 2/20 | 0.61 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.61 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.61 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL494194 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL6561739 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL10623365 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL116413 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| Dibutyl Sebacate SCHEMBL42655 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL494756 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL495198 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL495445 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL494447 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL494116 | 1.00 | DGKA (0.83) | DGKADNM1NAAAPAMPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580751-A2 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | Adora Animal Health Corporation (US) | 2025-07-09 | — | — | EP | claimed |
| US-12303528-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2025-05-20 | — | — | US | claimed |
| CN-116356440-B | Modified Taiji stone and application thereof in far infrared health-care degradable copolyester fiber | 浙江恒逸石化研究院有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-118978684-A | Binary polyether ester type defoamer and preparation method thereof | 江苏中浩远达环境工程有限公司 | 2024-11-19 | — | — | CN | claimed |
| US-20240342208-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-10-17 | — | — | US | claimed |
| CN-115305035-B | Glass cement for OLED sealing, encapsulation method of OLED element and OLED device | 深圳市首骋新材料科技有限公司 | 2024-08-20 | — | — | CN | claimed |
| WO-2024072942-A2 | SKIN PENETRATING FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA ANIMAL HEALTH CORPORATION (US) | 2024-04-04 | — | — | WO | claimed |
| CN-114573956-B | Preparation method of nano magnesium hydroxide modified degradable copolyester | 浙江恒逸石化研究院有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-117105798-A | Preparation method of nonandiamide MEA | 妆莱(广州)生物研究有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116918808-A | Application of fatty diacid ester compound | 沈阳恩柽研究院有限公司 | 2023-10-24 | — | — | CN | claimed |
| US-20020013294-A1 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | DUKE UNIVERSITY | 2002-01-31 | — | — | US | claimed |
| US-5716750-A | FIXING TONER; STRESS RELIEVING | EASTMAN KODAK COMPANY (US) | 1998-02-10 | — | — | US | claimed |
| EP-0606923-A2 | Melt processable biodegradable compositions and articles made therefrom | McNEIL-PPC, INC. (US) | 1994-07-20 | — | — | EP | claimed |
| EP-0277428-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-03-23 | — | — | EP | claimed |
| EP-0277428-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1988-08-10 | — | — | EP | claimed |
| US-4420602-A | HEATING DIISOCYANATE AND DICARBOXYLIC ACID, VENTING CARBON DIOXIDE, MELTING, DEGASSING | THE UPJOHN COMPANY (US) | 1983-12-13 | — | — | US | claimed |
| US-4358546-A | Spherical porous cross-linked copolymers of chloromethylstyrene and divinylbenzene and the derivative thereof | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-11-09 | — | — | US | claimed |
| US-4350616-A | SILVER CATALYST PROMOTED WITH CESIUM COMPOUND FOR VAPOR PHASE OXIDATION OF ETHYLENE | THE DOW CHEMICAL COMPANY (US) | 1982-09-21 | — | — | US | claimed |
| US-4248741-A | DEPOSITION OF SILVER AND PROMOTER, ON SUPPORT | THE DOW CHEMICAL COMPANY (US) | 1981-02-03 | — | — | US | claimed |
| US-4073858-A | RAILROAD DRAFT GEARS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-02-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013294-A1 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | BMP2, PLOD2, PTGDR2 | DGKA 208/4885DNM1 3121/4885NAAA 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.